CRP and dysplasia: After adjusting for categorical age, sex and surgery type, current use of NSAIDs was associated with increased levels of sVEGFR3 (OR: 2.61, 95% CI: 1.12–6.33) and GRO (OR: 2.55, 95% CI: 1.11–6.01) in controls and with higher levels of CRP (OR: 4.61, 95% CI: 1.47–15.64) in dysplasia cases (Tables 3 and 4).